China Resources Medical Holdings Company Limited (HKG:1515)
2.740
-0.030 (-1.08%)
May 15, 2026, 4:09 PM HKT
HKG:1515 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 495.94 | 565.88 | 257.68 | 265.86 | 417.92 |
Depreciation & Amortization | 584.93 | 618.9 | 610.86 | 486.41 | 182.88 |
Loss (Gain) From Sale of Assets | -2.06 | 11.19 | 2.39 | -5.41 | - |
Asset Writedown & Restructuring Costs | 0.03 | 32.15 | 351.81 | 108.83 | 11.15 |
Loss (Gain) From Sale of Investments | 18.17 | 22.15 | 145.87 | 22.18 | 371.56 |
Loss (Gain) on Equity Investments | -78.34 | -98.6 | -90.78 | -88.07 | -83.55 |
Stock-Based Compensation | - | - | - | 2.16 | 10.11 |
Other Operating Activities | 147.83 | 96.98 | 230.61 | 159.42 | -348.79 |
Change in Accounts Receivable | 142.31 | 118.03 | -111.25 | 109.17 | 131.47 |
Change in Inventory | 39.48 | -0.07 | 65.18 | -17.34 | 0.21 |
Change in Accounts Payable | -34.06 | -35.24 | 9.71 | -152.76 | -31.99 |
Change in Unearned Revenue | 4.45 | 2.23 | 17.21 | 8.54 | -0.09 |
Change in Other Net Operating Assets | 39.86 | -63.34 | -294.17 | -35.4 | 49.56 |
Operating Cash Flow | 1,359 | 1,270 | 1,195 | 863.59 | 710.43 |
Operating Cash Flow Growth | 6.95% | 6.29% | 38.39% | 21.56% | 10.37% |
Capital Expenditures | -514.13 | -563.69 | -486.68 | -466.28 | -198.43 |
Sale of Property, Plant & Equipment | 18.18 | 0.09 | 54.98 | 6.13 | 2.1 |
Cash Acquisitions | - | - | -3,768 | 173.92 | -669.61 |
Divestitures | - | - | - | 0.01 | - |
Investment in Securities | - | - | 872.18 | 381.34 | -1,096 |
Other Investing Activities | 169.75 | 18.88 | 705.46 | -589.13 | 26.26 |
Investing Cash Flow | -326.2 | -544.73 | -2,622 | -494.02 | -1,936 |
Short-Term Debt Issued | 500 | - | - | - | - |
Long-Term Debt Issued | 1,550 | 1,724 | 5,554 | 8,614 | 6,073 |
Total Debt Issued | 2,050 | 1,724 | 5,554 | 8,614 | 6,073 |
Short-Term Debt Repaid | -500 | - | - | -0.26 | -1.56 |
Long-Term Debt Repaid | -2,402 | -2,489 | -5,819 | -8,650 | -5,106 |
Total Debt Repaid | -2,902 | -2,489 | -5,819 | -8,651 | -5,107 |
Net Debt Issued (Repaid) | -852.45 | -764.34 | -265.28 | -36.68 | 965.15 |
Issuance of Common Stock | - | - | - | - | 0.54 |
Common Dividends Paid | -166.89 | -139.13 | -42.35 | -129.6 | -91.08 |
Other Financing Activities | -50.79 | -81.32 | -129.45 | -57.41 | -28.66 |
Financing Cash Flow | -1,070 | -984.8 | -437.08 | -223.69 | 845.96 |
Foreign Exchange Rate Adjustments | 0.08 | 0.5 | 0.14 | 2.73 | 2.34 |
Net Cash Flow | -37.71 | -258.76 | -1,864 | 148.61 | -377.32 |
Free Cash Flow | 844.41 | 706.57 | 708.44 | 397.31 | 512 |
Free Cash Flow Growth | 19.51% | -0.26% | 78.31% | -22.40% | 17.93% |
Free Cash Flow Margin | 9.20% | 7.17% | 7.01% | 5.03% | 11.51% |
Free Cash Flow Per Share | 0.67 | 0.56 | 0.56 | 0.32 | 0.41 |
Cash Interest Paid | 38.66 | 63.7 | 116.27 | 56.4 | 19.77 |
Cash Income Tax Paid | 132.16 | 235.69 | 163.4 | 143.84 | 135.99 |
Levered Free Cash Flow | 640.17 | 279.57 | 1,843 | 235.59 | 569.68 |
Unlevered Free Cash Flow | 660.14 | 317.7 | 1,915 | 270.53 | 579.83 |
Change in Working Capital | 192.04 | 21.62 | -313.31 | -87.79 | 149.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.